Furthermore, heightened expression of TPX2 in HCC promotes cell proliferation and invasion through AKT signaling activation and upregulation of MMP2/9, underscoring its potential as a therapeutic target for hepatocellular carcinoma (Liu et al., 2014). Here, TPX2 is linked to hepatocellular carcinoma.